Pernix Therapeutics Holdings, Inc. (PTX)
PTX Stock Chart More Charts
PTX Price/Volume Stats
Pernix Therapeutics Holdings, Inc. (PTX) Company Bio
Pernix Therapeutics Holdings, Inc. develops, manufactures, markets, and sells branded and generic pharmaceutical products. The companys product include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product. The company was founded in 1996 and is based in Morristown, New Jersey.